Title: Aarkstore - Peregrine Pharmaceuticals, Inc. - Product Pipeline Review - 2014
1Peregrine Pharmaceuticals, Inc. - Product
Pipeline Review - 2014
Category Pharmaceuticals Healthcare
- Browse Complete Report -
- http//www.aarkstore.com/pharmaceuticals-healthcar
e/63685/peregrine-pharmaceuticals-inc-product-pipe
line-review
2Peregrine Pharmaceuticals, Inc. - Product
Pipeline Review - 2014
3Summary
- Global Markets Directs, Peregrine
Pharmaceuticals, Inc. - Product Pipeline Review -
2014, provides an overview of the Peregrine
Pharmaceuticals, Inc.s pharmaceutical research
and development focus. - This report provides comprehensive information
on the current therapeutic developmental pipeline
of Peregrine Pharmaceuticals, Inc.s, complete
with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA)
and molecule type. It also reviews latest
updates, and featured news and press releases,
along with special features on late-stage and
discontinued projects. - Peregrine Pharmaceuticals, Inc. - Product
Pipeline Review - 2014report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team.
4Summary
- Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. -
- The report enhances decision making capabilities
and help to create effective counter strategies
to gain competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. -
- Note Certain sections in the report may be
removed or altered based on the availability and
relevance of data for the indicated disease.
5Scope
- - The report provides brief overview of Peregrine
Pharmaceuticals, Inc. including business
description, key information and facts, and its
locations and subsidiaries - - The report reviews current pipeline of
Peregrine Pharmaceuticals, Inc.s human
therapeutic division and enlists all their major
and minor projects - - The report features product description and
descriptive mechanism of action for key pipeline
products along with the products developmental
history and major milestones - - Special feature on out-licensed and partnered
product portfolio - - The report summarizes all the dormant and
discontinued pipeline projects - - Latest company statement
- - Latest news and deals relating to the Peregrine
Pharmaceuticals, Inc.s pipeline products
6Reasons to buy
- - Evaluate Peregrine Pharmaceuticals, Inc.s
strategic position with total access to detailed
information on its product pipeline - - Assess the growth potential of Peregrine
Pharmaceuticals, Inc. in its therapy areas of
focus - - Identify new drug targets and therapeutic
classes in the Peregrine Pharmaceuticals, Inc.s
RD portfolio and develop key strategic
initiatives to reinforce pipeline in those areas - - Exploit in-licensing opportunities by
identifying windows of opportunity to fill
portfolio gaps - - Develop strategic initiatives by understanding
the focus areas of Peregrine Pharmaceuticals,
Inc. and exploit collaboration and partnership
opportunities - - Identify emerging players with potentially
strong product portfolio and create effective
counter-strategies to gain competitive advantage - - Plan mergers and acquisitions effectively by
identifying the most promising pipeline of
Peregrine Pharmaceuticals, Inc.
7Table of Content
List of Tables 3List of Figures 4Peregrine
Pharmaceuticals, Inc. Snapshot 5Peregrine
Pharmaceuticals, Inc. Overview 5Key Information
5Key Facts 5Peregrine Pharmaceuticals, Inc. -
Research and Development Overview 6Key
Therapeutic Areas 6Peregrine Pharmaceuticals,
Inc. - Pipeline Review 9Pipeline Products by
Stage of Development 9Pipeline Products -
Monotherapy 10Pipeline Products - Partnered
Products 11Partnered Products/Combination
Treatment Modalities 12Pipeline Products -
Out-Licensed Products 13
8Table of Content
Out-Licensed Products/Combination Treatment
Modalities 14Peregrine Pharmaceuticals, Inc. -
Pipeline Products Glance 15Peregrine
Pharmaceuticals, Inc. - Late Stage Pipeline
Products 15Phase III Products/Combination
Treatment Modalities 15Peregrine
Pharmaceuticals, Inc. - Clinical Stage Pipeline
Products 16Phase II Products/Combination
Treatment Modalities 16Phase I
Products/Combination Treatment Modalities
17Peregrine Pharmaceuticals, Inc. - Early Stage
Pipeline Products 18Preclinical
Products/Combination Treatment Modalities
18Discovery Products/Combination Treatment
Modalities 19Peregrine Pharmaceuticals, Inc. -
Drug Profiles 20bavituximab 20
9List Of Tables
- Peregrine Pharmaceuticals, Inc., Key Information
5Peregrine Pharmaceuticals, Inc., Key Facts
5Peregrine Pharmaceuticals, Inc. - Pipeline by
Indication, 2014 8Peregrine Pharmaceuticals,
Inc. - Pipeline by Stage of Development, 2014
9Peregrine Pharmaceuticals, Inc. - Monotherapy
Products in Pipeline, 2014 10Peregrine
Pharmaceuticals, Inc. - Partnered Products in
Pipeline, 2014 11Peregrine Pharmaceuticals, Inc.
- Partnered Products/ Combination Treatment
Modalities, 2014 12Peregrine Pharmaceuticals,
Inc. - Out-Licensed Products in Pipeline, 2014
13Peregrine Pharmaceuticals, Inc. - Out-Licensed
Products/ Combination Treatment Modalities, 2014
14Peregrine Pharmaceuticals, Inc. - Phase III,
2014 15Peregrine Pharmaceuticals, Inc. - Phase
II, 2014 16Peregrine Pharmaceuticals, Inc. -
Phase I, 2014 17
10List of Figures
- Peregrine Pharmaceuticals, Inc. - Pipeline by Top
10 Indication, 2014 7Peregrine Pharmaceuticals,
Inc. - Pipeline by Stage of Development, 2014
9Peregrine Pharmaceuticals, Inc. - Monotherapy
Products in Pipeline, 2014 10Peregrine
Pharmaceuticals, Inc. - Partnered Products in
Pipeline, 2014 11Peregrine Pharmaceuticals, Inc.
- Out-Licensed Products in Pipeline, 2014
13Peregrine Pharmaceuticals, Inc. - Pipeline by
Top 10 Target, 2014 28Peregrine Pharmaceuticals,
Inc. - Pipeline by Top 10 Route of
Administration, 2014 29Peregrine
Pharmaceuticals, Inc. - Pipeline by Top 10
Molecule Type, 2014 30Peregrine Pharmaceuticals,
Inc. - Pipeline Products by Top 10 Mechanism of
Action, 2014 31
11Related Reports
- Global Neurosurgery Market 2015-2019
- Active Pharmaceutical Ingredients (API) Market in
India 2015-2019 - BrainStorm Cell Therapeutics Inc. (BCLI) -
Financial and Strategic SWOT Analysis Review - Ampio Pharmaceuticals, Inc. (AMPE) - Financial
and Strategic SWOT Analysis Review - MiMedx Group, Inc (MDXG) - Financial and
Strategic SWOT Analysis Review
12Related Reports
- Threshold Pharmaceuticals, Inc. (THLD) -
Financial and Strategic SWOT Analysis Review - MEI Pharma, Inc. (MEIP) - Financial and Strategic
SWOT Analysis Review - Titan Pharmaceuticals, Inc. (TTNP) - Financial
and Strategic SWOT Analysis Review - RedHill Biopharma Ltd. (RDHL) - Financial and
Strategic SWOT Analysis Review - Pharmaceuticals Healthcare Market Research
Reports
13- Peregrine Pharmaceuticals, Inc. - Product
Pipeline Review 2014 - Published Oct 2014 44 Pages
- Peregrine Pharmaceuticals, Inc. - Product
Pipeline Review - 2014report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications.
Price
Format Price
PDF 1500
Site Licence 3000
Enterprise Wide Licence 4500
14Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
- You Can Visit http//www.aarkstore.com
- OR Mail us at contact_at_aarkstore.com
- Blog
- http//www.aarkstore.com/blog/
- Conference
- http//conference.aarkstore.com/
- News
- http//www.aarkstore.com/news